30:43

Aernout van Haarst Presents Optimizing Early Clinical Trials in Special Populations

47:37

Onsite Pharmacy Compounding for Your Phase 1 Clinical Study

42:52

Role of DMPK in Drug Discovery and Development

54:18

Clinical and Bioanalytical Aspects of Immune Monitoring via ELISpot

29:35

Introduction to Mass Spectrometry: A Case Study with Dr. Robert Parise

58:30

AAV Vector Shedding Assay—Best Practices in Clinical Gene Therapy Method Development

21:27

RI-ADE ADME 101: Non-clinical pharmacokinetics studies using radio-labeled compounds

1:00:13

Bioanalytical Support of Biosimilars Expect the Unexpected